Senores Pharmaceuticals Limited (NSE:SENORES)
India · Delayed Price · Currency is INR 1,178.50
+3.50 (0.30%)
Nov 11, 2026, 1:15 PM IST
Senores Pharmaceuticals Market Cap
Senores Pharmaceuticals has a market cap or net worth of 54.27 billion as of November 10, 2026. It is the 13,447th most valuable company in the world and the 818th biggest in India. Its market cap has increased by 49.57% in one year.
Market Cap
54.27B
Enterprise Value
57.72B
Revenue
7.19B
Global Rank
Country Rank
#818 India
PE Ratio
40.34
ChartMarket Cap Chart
Since December 30, 2024, Senores Pharmaceuticals's market cap has increased from 25.65B to 54.27B, an increase of 111.56%. That is a compound annual growth rate of 49.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 54.27B | 43.33% |
| Dec 31, 2025 | 37.87B | 44.60% |
| Dec 31, 2024 | 26.19B | 2.07% |
| Dec 30, 2024 | 25.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.57T |
| Divi's Laboratories | 3.07T |
| Laurus Labs | 1.33T |
| Lenskart Solutions | 1.25T |
| Nephrocare Health Services | 62.64B |
| Innova Captab | 61.23B |
| Orchid Pharma | 52.94B |
| Supriya Lifescience | 50.55B |